Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleTheranostics

Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors

Price A. Jackson, Michael S. Hofman, Rodney J. Hicks, Mark Scalzo and John Violet
Journal of Nuclear Medicine July 2020, 61 (7) 1030-1036; DOI: https://doi.org/10.2967/jnumed.119.233411
Price A. Jackson
1Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
2Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael S. Hofman
1Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
2Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodney J. Hicks
1Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
2Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Scalzo
1Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Violet
3Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 61 no. 7 1030-1036
DOI 
https://doi.org/10.2967/jnumed.119.233411
PubMed 
31806772

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication September 3, 2019
  • Accepted for publication November 14, 2019
  • Published online July 1, 2020.

Article Versions

  • previous version (December 5, 2019 - 10:37).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Price A. Jackson1,2,
  2. Michael S. Hofman1,2,
  3. Rodney J. Hicks1,2,
  4. Mark Scalzo1 and
  5. John Violet3
  1. 1Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
  2. 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; and
  3. 3Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
  1. For correspondence or reprints contact: Price A. Jackson, Department of Cancer Imaging, Peter MacCallum Cancer Center, 305 Grattan St., Melbourne Victoria, 3000 Australia. E-mail: price.jackson{at}petermac.org
View Full Text

Statistics from Altmetric.com

Cited By...

  • 21 Citations
  • Google Scholar

Article usage

Article usage: December 2019 to May 2022

AbstractFullPdf
Dec 2019439089
Jan 2020153038
Feb 2020126021
Mar 2020122019
Apr 2020123017
May 202090017
Jun 202068043
Jul 2020144023176
Aug 202062334123
Sep 20202323072
Oct 20202623287
Nov 20201671352
Dec 20201882162
Jan 2021527583
Feb 2021636070
Mar 20215193107
Apr 2021617295
May 2021577281
Jun 20214110977
Jul 2021269076
Aug 20213111164
Sep 2021439267
Oct 202131120101
Nov 2021458973
Dec 2021398582
Jan 2022378254
Feb 20224610283
Mar 20224512889
Apr 202246105100
May 20224317695
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 61 (7)
Journal of Nuclear Medicine
Vol. 61, Issue 7
July 1, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
Price A. Jackson, Michael S. Hofman, Rodney J. Hicks, Mark Scalzo, John Violet
Journal of Nuclear Medicine Jul 2020, 61 (7) 1030-1036; DOI: 10.2967/jnumed.119.233411

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
Price A. Jackson, Michael S. Hofman, Rodney J. Hicks, Mark Scalzo, John Violet
Journal of Nuclear Medicine Jul 2020, 61 (7) 1030-1036; DOI: 10.2967/jnumed.119.233411
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • KEY POINTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • Will SPECT/CT Cameras Soon Be Able to Display Absorbed Doses? Dosimetry from Single-Activity-Concentration Measurements
  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • A Novel Time-Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After 177Lu-DOTATATE
  • Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies
  • Will SPECT/CT Cameras Soon Be Able to Display Absorbed Doses? Dosimetry from Single-Activity-Concentration Measurements
  • Google Scholar

More in this TOC Section

Theranostics

  • The prognostic value of post-treatment PSMA and FDG PET/CT in metastatic, castration-resistant prostate cancer treated with 177LuPSMA-617 and NOX66 in a phase I/II trial (LuPIN).
  • A novel dimeric FAP-targeting small molecule-radio conjugate with high and prolonged tumour uptake
  • 89Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted 227Th-conjugate therapy in mice
Show more Theranostics

Clinical

  • TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
  • Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
Show more Clinical

Similar Articles

Keywords

  • 177Lu-PSMA-617
  • radiation dosimetry
  • radiobiology
  • Image Processing
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire